Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Observational Study on the Patients With Pain Medications
This study is ongoing, but not recruiting participants.
Sponsored by: Johnson & Johnson Taiwan Ltd
Information provided by: Johnson & Johnson Taiwan Ltd
ClinicalTrials.gov Identifier: NCT00771212
  Purpose

This is a Phase IV, Multi-center, Non-interventional, Observational Study to describe the usage of pain treatment, the demographics, clinical characteristics of pain patients, current treatments, the outcomes, reason of switch of the medication during pain treatment in Taiwan.


Condition Phase
Pain
 Phase IV

U.S. FDA Resources
Study Type: Observational
Study Design: Prospective
Official Title: Observational Study on the Patients With Pain Medications

Further study details as provided by Johnson & Johnson Taiwan Ltd:

Estimated Enrollment: 2500
Detailed Description:

This is a Phase IV, Multi-center, Non-interventional, prospective observational study to describe the usage of pain treatment, the demographics, clinical characteristics of pain patients, current treatments, the outcomes, and reason of switching of the medication during pain treatment in Taiwan in order to gain understanding the Taiwan pain control status. Precise estimates of the prevalence of different pain syndromes in the Taiwan are difficult to ascertain. In Taiwan, there are no approved documentations could show the most effect standard medication for treatment in pain patients currently. The data will be collected at baseline and every 2 weeks for 2 months. Safety data will not be collected unless the patients have taken Johnson & Johnson's medication and have serious adverse event.

Observational study with no study medication administered.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Outpatients
  • Patients must have pain, previously treated with/without medication and have a VAS (Visual analogue scale) score recorded at the enrolment time
  • Patient must have a VAS score >4

Exclusion Criteria:

  • Patients who are receiving any investigational drug during the study
  • Patients with known or suspected for psychotic disease or mental retardation
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00771212

Sponsors and Collaborators
Johnson & Johnson Taiwan Ltd
Investigators
Study Director: Johnson & Johnson Taiwan, Ltd. Clinical Trial Johnson & Johnson Taiwan Ltd
  More Information

Study ID Numbers: CR014656
Study First Received: October 10, 2008
Last Updated: October 10, 2008
ClinicalTrials.gov Identifier: NCT00771212  
Health Authority: Taiwan: Department of Health

Keywords provided by Johnson & Johnson Taiwan Ltd:
Taiwan
Observational
Pain

Study placed in the following topic categories:
Pain

ClinicalTrials.gov processed this record on January 16, 2009



U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services